San Diego’s vibrant life sciences industry, a cornerstone of the local economy, is facing significant challenges due to recent changes in funding from the National Institutes of Health (NIH). The NIH, a crucial supporter of medical research, has seen its funding policies shift under the second Trump administration, impacting research institutions like UC San Diego and others in the area.
Impact on Local Economy
UC San Diego recently celebrated a $5 million grant renewal from the NIH, aimed at recruiting early-career researchers. However, this positive news is overshadowed by a broader reduction in NIH funding for cancer research in the region, amounting to tens of millions of dollars. This contradiction highlights a tension between Congress’s increased investment in health research and the executive branch’s restrictive spending policies.
San Diego ranks 9th nationwide in NIH grant dollars, receiving over $1 billion in 2025. These funds are vital for the region’s 2,000 life sciences companies, which employ 167,000 people—more than 10% of the local workforce. Yet, the administration’s stance has led to significant policy changes, including the termination of grants related to health disparities and attempts to reduce indirect cost rates for universities.
Policy Shifts and Challenges
Since January 2025, the Trump administration has reduced support for the NIH, proposing a nearly 40% budget cut, which Congress ultimately rejected. Additionally, the NIH has faced staffing challenges, losing 20% of its workforce, which has slowed the pace of grant awards. This slowdown has affected the number of new grants awarded to San Diego, with a noticeable decrease in 2026 compared to previous years.
State lawmakers in California are considering measures to mitigate these federal challenges. A proposed bill, S.B. 895, aims to establish a state-funded version of the NIH within the University of California, backed by a $12 billion bond measure. While controversial, this initiative underscores the state’s commitment to supporting biomedical research independently.
The future of San Diego’s life sciences sector depends not only on federal and state funding but also on the ability to attract and retain early-career researchers and foster breakthrough discoveries. As the region navigates these challenges, the outcome will significantly influence its economic and scientific landscape.
Original reporting: Voice of San Diego — read the source article.
